Kapil Proteins Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
- Paid Up Capital ₹ 7.41 Cr
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.50 Cr
- Satisfied Charges ₹ 6.00 Cr
- Revenue Growth 6.33%
- Profit Growth 91.22%
- Ebitda 141.72%
- Net Worth 10.21%
- Total Assets 28.93%
About Kapil Proteins
Kapil Proteins Private Limited (KPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 July 2012 and has a history of 12 years and seven months. Its registered office is in Yavatmal, Maharashtra, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 7.41 Cr.
The company currently has active open charges totaling ₹9.50 Cr. The company has closed loans amounting to ₹6.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pradeep Chakkarwar, Prashnsha Chakkarwar, Vijay Chakkarwar, and One other member serve as directors at the Company.
Company Details
-
Location
Yavatmal, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U15122MH2012PTC232928
-
Company No.
232928
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Jul 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Kapil Proteins?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pradeep Chakkarwar | Director | 04-Jul-2012 | Current |
Prashnsha Chakkarwar | Director | 01-Oct-2015 | Current |
Vijay Chakkarwar | Director | 04-Jul-2012 | Current |
Om Chakkarwar | Director | 06-Oct-2022 | Current |
Financial Performance of Kapil Proteins.
Kapil Proteins Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.33% increase. The company also saw a substantial improvement in profitability, with a 91.22% increase in profit. The company's net worth Soared by an impressive increase of 10.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Kapil Proteins?
In 2022, Kapil Proteins had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹9.50 Cr
₹6.00 Cr
Charges Breakdown by Lending Institutions
- Others : 9.50 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
02 Nov 2022 | Others | ₹4.00 Cr | Open |
11 Jan 2019 | Others | ₹5.50 Cr | Open |
29 Jan 2015 | Others | ₹6.00 Cr | Satisfied |
How Many Employees Work at Kapil Proteins?
Unlock and access historical data on people associated with Kapil Proteins, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kapil Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kapil Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.